↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Rauch N.) "

Search: WFRF:(Rauch N.)

Result 1-10 of 100

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
2.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
3.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
4.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
5.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
6.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)
7.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)
8.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)
9.	Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A 2018 In: Science. - : American Association for the Advancement of Science. - 0036-8075 .- 1095-9203. ; 361:6398 Journal article (peer-reviewed)
10.	Abbas, E., et al. (author) J/psi Elliptic Flow in Pb-Pb Collisions at root s(NN)=2.76 TeV 2013 In: Physical Review Letters. - 1079-7114. ; 111:16 Journal article (peer-reviewed)abstract We report on the first measurement of inclusive J/psi elliptic flow v(2) in heavy-ion collisions at the LHC. The measurement is performed with the ALICE detector in Pb-Pb collisions at root s(NN) = 2.76 TeV in the rapidity range 2.5 < y < 4.0. The dependence of the J/psi v(2) on the collision centrality and on the J/psi transverse momentum is studied in the range 0 <= p(T) < 10 GeV/c. For semicentral Pb-Pb collisions at root s(NN) = 2.76 TeV, an indication of nonzero v(2) is observed with a largest measured value of v(2) = 0.116 +/-0.046(stat) +/- 0.029(syst) for J/psi in the transverse momentum range 2 <= p(T) < 4 GeV/c. The elliptic flow measurement complements the previously reported ALICE results on the inclusive J/psi nuclear modification factor and favors the scenario of a significant fraction of J/psi production from charm quarks in a deconfined partonic phase.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 100

Refine your search

Type of publication: journal article (98); conference paper (2)

Type of content: peer-reviewed (97); other academic/artistic (3)

Author/Editor: Rauch, L. (32); Zhu, H. (23); Wang, H. (20); Weber, M. (19); Berger, T. (19); Colijn, A. P. (18); show more...; Aalbers, J. (18); Agostini, F. (18); Amaro, F. D. (18); Aprile, E. (18); Arneodo, F. (18); Baudis, L. (18); Brown, A. (18); Brown, E. (18); Bruenner, S. (18); Bruno, G. (18); Budnik, R. (18); Alfonsi, M. (18); Cardoso, J. M. R. (18); Cichon, D. (18); Coderre, D. (18); Cussonneau, J. P. (18); Decowski, M. P. (18); Fieguth, A. (18); Fulgione, W. (18); Di Gangi, P. (18); Di Giovanni, A. (18); Garbini, M. (18); Geis, C. (18); Greene, Z. (18); Hasterok, C. (18); Kaminsky, B. (18); Kish, A. (18); Landsman, H. (18); Lang, R. F. (18); Lindemann, S. (18); Lindner, M. (18); Lopes, J. A. M. (18); Masbou, J. (18); Messina, M. (18); Micheneau, K. (18); Molinario, A. (18); Murra, M. (18); Naganoma, J. (18); Oberlack, U. (18); Pelssers, Bart (18); de Perio, P. (18); Persiani, R. (18); Piastra, F. (18); Plante, G. (18); show less...

University: Karolinska Institutet (38); Stockholm University (34); Uppsala University (22); Lund University (16); University of Gothenburg (6); Royal Institute of Technology (5); show more...; Chalmers University of Technology (2); RISE (2); Umeå University (1); The Swedish School of Sport and Health Sciences (1); Linnaeus University (1); show less...

Language: English (100)

Research subject (UKÄ/SCB): Natural sciences (52); Medical and Health Sciences (21); Engineering and Technology (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view